We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+8.74%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$19.4B
AUM Growth
+$2.92B
(+18%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
9.28%
Top 10 Holdings %
Top 10 Hldgs %
20.62%
Holding
1,394
New
273
Increased
343
Reduced
316
Closed
453
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$694M |
| 2 |
Philip Morris
PM
|
+$316M |
| 3 |
Johnson & Johnson
JNJ
|
+$315M |
| 4 |
Merck
MRK
|
+$303M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$248M |
| 2 |
Micron Technology
MU
|
+$212M |
| 3 |
RAD
Rite Aid Corporation
RAD
|
+$196M |
| 4 |
Comcast
CMCSA
|
+$165M |
| 5 |
GSK
GSK
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.45% |
| 2 | Energy | 18.88% |
| 3 | Healthcare | 17.92% |
| 4 | Financials | 10.19% |
| 5 | Consumer Staples | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Monolithic Power Systems
MPWR
$66.8B
| $2.34M | 0.01% |
55,216
-2,081
| -4% | -$80.7K |
|
552
CONMED
CNMD
$1.49B
| $2.34M | 0.01% |
+52,915
| New | +$2.4M |
|
|
GNCMA
553
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $2.33M | 0.01% |
209,916
+166,714
| +386% | +$1.82M |
|
554
Weis Markets
WMK
$1.89B
| $2.31M | 0.01% |
50,516
| – | – |
|
555
CAE Inc. Common Shares
CAE
$8.61B
| $2.31M | 0.01% |
176,116
-444,234
| -72% | -$5.94M |
|
556
Kemper
KMPR
$1.76B
| $2.3M | 0.01% |
62,314
-23,453
| -27% | -$868K |
|
557
United Fire Group
UFCS
$1.41B
| $2.29M | 0.01% |
78,192
+24,593
| +46% | +$702K |
|
|
EVRI
558
DELISTED
Everi Holdings
EVRI
| $2.29M | 0.01% |
257,025
-382,649
| -60% | -$3.04M |
|
|
HNGR
559
DELISTED
Hanger Inc.
HNGR
| $2.29M | 0.01% |
72,653
-21,064
| -22% | -$678K |
|
560
Vishay Intertechnology
VSH
$5.03B
| $2.27M | 0.01% |
146,679
-258,317
| -64% | -$3.83M |
|
561
EQT Corp
EQT
$32.3B
| $2.26M | 0.01% |
+38,845
| New | +$2.23M |
|
562
Selective Insurance
SIGI
$5.77B
| $2.25M | 0.01% |
+91,180
| New | +$2.15M |
|
|
MHR
563
DELISTED
MAGNUM HUNTER RESOURCES CORP (DEL)
MHR
| $2.25M | 0.01% |
274,686
+264,686
| +2,647% | +$2.16M |
|
564
FormFactor
FORM
$9B
| $2.25M | 0.01% |
269,940
+45,286
| +20% | +$301K |
|
565
Allstate
ALL
$69.6B
| $2.24M | 0.01% |
38,171
-124,372
| -77% | -$7.17M |
|
|
SPNC
566
DELISTED
Spectranetics Corp
SPNC
| $2.23M | 0.01% |
97,541
+42,859
| +78% | +$994K |
|
|
SGNT
567
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $2.23M | 0.01% |
86,298
+8,372
| +11% | +$186K |
|
|
ANH
568
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $2.23M | 0.01% |
+432,288
| New | +$2.3M |
|
|
REXX
569
DELISTED
Rex Energy Corporation
REXX
| $2.23M | 0.01% |
+12,594
| New | +$2.44M |
|
570
Central Garden & Pet Co Class A
CENTA
$2.54B
| $2.22M | 0.01% |
302,139
+131,751
| +77% | +$882K |
|
571
Interactive Brokers
IBKR
$38.8B
| $2.21M | 0.01% |
380,104
+106,092
| +39% | +$610K |
|
|
CYT
572
DELISTED
CYTEC INDS INC
CYT
| $2.21M | 0.01% |
+41,970
| New | +$2.07M |
|
573
KB Financial Group
KB
$42.6B
| $2.19M | 0.01% |
62,986
-223,875
| -78% | -$7.79M |
|
|
IVC
574
DELISTED
Invacare Corporation
IVC
| $2.17M | 0.01% |
117,945
+45,659
| +63% | +$775K |
|
|
AKRX
575
DELISTED
Akorn Inc
AKRX
| $2.15M | 0.01% |
64,823
-370,053
| -85% | -$9.7M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2014 Portfolio in Review
As of Q2 2014, Arrowstreet Capital held 1,394 positions worth $19.4B, up 18% from $16.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Arrowstreet Capital deployed $1.81B of net new capital in Q2 2014, opening 273 new positions and adding to 343 existing holdings. Its largest new stake was Johnson & Johnson: 3,117,484 shares worth $326M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $248M trimmed.
- Arrowstreet Capital's largest Q2 2014 buy was Johnson & Johnson: 3,117,484 shares worth $326M.
- Arrowstreet Capital added most to Apple in Q2 2014, an estimated $694M increase.
- Arrowstreet Capital's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $248M.
- Arrowstreet Capital fully exited Comcast in Q2 2014, selling an estimated $165M.
- Arrowstreet Capital's ten largest holdings make up 21% of its $19.4B portfolio in Q2 2014.
- Arrowstreet Capital opened 273 new positions and closed 453 in Q2 2014.
- Arrowstreet Capital's portfolio value rose 18% quarter-over-quarter to $19.4B.
Based on Arrowstreet Capital's 13F filing for Q2 2014, filed 14 Aug 2014.